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Susceptibility of microcosm
subgingival dental plaques to lethal
photosensitization
I. U. Allan1∗, J. F. O’Neill2 and C. K. Hope3
A B S T R A C T
Photodynamic therapy (PDT) offers potential as a non-invasive treatment of
periodontal disease. In this study, microcosmbiofilmswere grown in vitro under
conditions designed to mimic subgingival plaques typically found in patients
with periodontitis. To investigate potential PDT modalities, biofilms were
exposed to light from a helium/neon laser in conjunction with a photosensitizer,
toluidine blue O (TBO), at varying output and concentration, respectively.
To determine cytotoxic effects, viability profiling was undertaken on whole
biofilms using standard plating methods, and on horizontal cross-sections
of biofilms using confocal laser-scanning microscopy (CLSM) in conjunction
with a differential viability stain. A light energy dose of 94.5 J in combination
with 81.7µM TBO was found to be optimal, achieving significant kills of over
97%. CLSM enabled visualization of the effects of PDT in three dimensions.
Viability profiling of the CLSM images revealed that lethal photosensitization
was most effective in the upper layers of biofilm. PDT was found to reduce the
viability of subgingivally modelled plaques in vitro by a magnitude similar to
that of chlorhexidine digluconate, which is commonly used to treat periodontal
disease. The findings of this study indicate that PDT may be an effective
alternative to conventional modalities in the treatment of periodontal disease.
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INTRODUCTION
Periodontal disease is caused by the accumulation of
subgingival plaque biofilm near the gingival margin
and is responsible for up to 60% of tooth loss in
the UK. Chronic marginal gingivitis probably affects
the whole dentate population at some stage and is
characterized by inflammation of the gum margin. If
the build-up of gum marginal plaque is left unchecked,
gingivitis can develop into the more serious condition
of chronic adult periodontitis (Pihlstrom et al., 2005).
This condition is characterized by the migration of the
junctional epithelium tissue at the base of the gingival
crevice down the tooth to form a periodontal pocket.
The cause of this pocketing has been attributed to tissue
destruction as a consequence of bacterial stimulation
of host degradative enzyme production (e.g. matrix
metalloproteinases) and invasion of host cells (Amano,
2003; Bodet et al., 2007). The (probing) depth of the
periodontal pocket is used as an indicator of the spread
of the disease and the Adult Dental Health Survey 1998
(Kelly et al., 2000) revealed that 54% of the UK adult
dentate population had probing depths greater than
3.5mm (moderate periodontal disease) whilst 8% of the
population had a loss of attachment over 5.5mm (severe
destructive periodontitis). The annual cost of the UK
National Health Service (NHS) periodontal therapy in
2001/2002 was £174 million on 15.5 million treatment
episodes (Chapple, 2004). Conventional periodontal
therapy routinely involves scaling and root planing,
which may be complemented with adjunct antimicrobial
chemotherapy, such as doxycycline (Tuter et al., 2007).
Bacteria harboured within biofilms are notoriously
recalcitrant to antimicrobial agents (Millward & Wilson,
1989; Anwar et al., 1990; Costerton et al., 2003) and
their eradication represents a formidable challenge where
they are associated with disease. The mechanisms by
which biofilms resist conventional antimicrobial agents
are generally considered to be multi-factorial, although
current understanding is that the production of high
numbers of essentially invulnerable persister cells, in
response to shock proteins or “alarmones”, is the most
significant of these factors (Gilbert et al., 2002b).
Treatment of bacterial infections by photodynamic
therapy (PDT) offers an alternative to the use of
antimicrobial agents (Malik et al., 1990) and to invasive
dental procedures, which are associated with patient
trauma. The bactericidal effect associated with PDT
(known as lethal photosensitization) is caused by the
generation of cytotoxic free radicals, such as singlet
oxygen, when a photoreactive agent (photosensitizer) is
excited by light of an appropriate wavelength (Malik et al.,
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1990). PDT has been used clinically to treat a number of
systemic conditions including tumour (Choi et al., 2006).
Interest in its application to treat bacterial infections
is gaining momentum – the treatment of periodontal
disease being one of themost promising (Meisel &Kocher,
2005). A major benefit of PDT is that the bactericidal
effect is localized to areas that are treated with both
photosensitizer and light, preventing disruption of the
indigenous microflora at sites distal to the treated area
(Wilson, 2004). The non-specific mode of action of PDT,
expressly the generation of singlet oxygen, means that
the acquisition of bacterial resistance to these agents is
unlikely.
Previous studies have examined the effects of PDT
on single-species biofilms using streptococci to model
supragingival plaque in conditions associated with onset
of dental caries (Zanin et al., 2005, 2006) and Streptococcus
pyogenes to model a skin biofilm (Hope & Wilson, 2006).
However, PDT also offers a promising, non-invasive
treatment for periodontal disease. Previously, it was
reported that toluidine blue O (TBO) and helium/neon
(HeNe) laser light could kill significant numbers of
bacteria associated with periodontal disease, using a
simple systemwherebacteriawere grownonnitrocellulose
membranes (O’Neill et al., 2002). In this investigation
we describe the modelling of subgingival plaque using a
sophisticated in vitromodel more representative of in vivo
conditions.
The aim of this study therefore was to investigate
the susceptibility of microcosm subgingival periodontal
plaques grown in a constant-depth film fermenter (CDFF)
to PDT using a range of biofilm viability profiling
techniques. We also compared the effectiveness of PDT
with the commonly used oral antimicrobial chlorhexidine
digluconate (CHX), representative of a conventional, non-
invasive modality.
MATERIALS AND METHODS
Subgingival plaque inoculum
Subgingival plaque samples were obtained from ten pa-
tients attending the EastmanDentalHospital, London, for
treatment of moderate-to-advanced adult periodontitis.
Each sample consisted of the contents of at least two
periodontal pockets from each patient. The samples
were pooled and mixed in pre-reduced BHI (brain–heart
infusion) broth (Oxoid, Basingstoke,UK) containing 10%
(v/v) glycerol and then aliquoted into 1ml volumes and
stored at −70 ◦C, to generate a bank of homogeneous
innocula for use throughout this series of experiments.
Two vials of homogenized plaques were used as the
inoculum to produce the biofilms in vitro. Compositional
studies (using culture and molecular methods) on
biofilms produced from this pooled inoculum, using
the method described below, demonstrated the presence
of many of the genera found in subgingival plaque
including Veillonella, Streptococcus, Propionibacterium,
Eubacterium, Micrococcus, Actinomyces, Fusobacterium
and Porphyromonas (O’Neill, 2006), the last three genera
being especially associated with periodontal disease.
Production of microcosm subgingival dental
plaques
Operation of a CDFF (University of Wales, Cardiff, UK)
to produce multi-species oral biofilms modelling those
associated with periodontal disease has been described
(Allan et al., 2002; Hope & Wilson, 2006). In this
study, to model the microaerophilic conditions found in
periodontal pockets (Mettraux et al., 1984), the CDFF
was operated by continuous flushing (60 cm3/min) with
a gas mixture consisting of 95% N2, 3% CO2, 2% O2.
The growth medium used to enable propagation of
biofilms from the microcosm plaques consisted of RPMI
medium (60%) (Sigma, Poole, UK) and horse serum
(40%) (Oxoid, Basingstoke, UK) supplemented with
0.5µg menadione/ml and 5.0µg hemin/ml. The CDFF
was housed within an incubator at 37 ◦C. The substratum
for subgingival plaque is enamel/cementum, themineral
component of which is similar to hydroxyapatite (HA).
HAdiscs were therefore used as the substratum for biofilm
formation.TheCDFFhoused15 samplepansona rotating
turntable, each pan containing five HA discs of 5mm
diameter. Discs were recessed to a depth of 100µm.
The inoculum was added to 500ml of growth medium
and pumped onto the rotating HA substrata for 8 h, at a
rate of 1ml/min. The CDFF was then connected to fresh
medium, which was supplied at 0.1ml/min, and biofilms
were then grown for 7 days before being removed for
experimentation.
Photosenitization and laser application
TBO(Sigma)wasused at concentrations of 32.7, 65.4, 81.7
or 163.4µM in 0.85% (v/v) saline. The laser used was an
HeNegas laser (Spectra-Physics,Darmstadt-Kranichstein,
Germany) with ameasured power output of 35mW. Light
was emitted in a collimatedbeamof3.5mmdiameter,with
wavelength of 632.8 nm. To irradiate biofilms, laser light
was passed through a lens (magnification 2×), allowing
light coverage of the entire biofilm surface.
To test biofilm susceptibility to TBO/HeNe laser light,
pans were removed and the biofilm-containing discs
removed and placed in microtitre plate wells. TBO (10µl)
was added to each biofilm for sensitization. Laser light
intensities of 63 J (163.8 J/cm2) and 95.4 J (248 J/cm2)
were employed (L+S+). Controls were: TBO in the
absence of laser light (L−S+); and addition of 10µl sterile
saline, with or without laser light (L+S− and L−S−,
respectively). In addition to controlling for laser light and
TBO exposure, L−S− also served to determine whether
exposure to an aerobic atmosphere for the duration of
the experiment had any effect on bacterial viability. A
pre-exposure time of 5min (in the absence of light)
was applied to allow the solutions to penetrate into the
biofilm. The L+S+ and L+S− samples were exposed
to laser light for 15min. Discs were then immersed in
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1ml pre-reduced BHI broth and biofilms resuspended by
vortexing for 60 s. The total number of viable culturable
bacteria (colony-forming units per millilitre (c.f.u./ml))
from resuspended biofilms before and after treatment was
determined by viable counting on Fastidious Anaerobe
Agar (FAA) (Bioconnections, Leeds, UK) containing 5%
(v/v) defibrinated horse blood (E & O Laboratories,
Bonnybridge, UK). Duplicate 25µl aliquots were spread
over the surface of FAA plates and the plates were
incubated for 7 days at 37 ◦C in an anaerobic atmosphere.
The resultant colonies were counted.
CLSM of biofilms subjected to PDT
Biofilms were subjected to either PDT using 63 J HeNe
laser light and 81.7µM TBO, or no treatment, as
described above. Post PDT, biofilms were then placed into
aminiature Petri dish, biofilm uppermost and stained
using the BacLightTM bacterial viability kit (Molecular
Probes, Oregon, USA) with 5min stain penetration time
in darkness. Scans were taken of the biofilms using a
Leica DMLFS fixed-stage microscope with a Leica TCS
SP confocal scan-head. The objective lens was a 63×HCX
water immersiondipping lens. Confocal image stackswere
captured of both the viable (488 nm) and non-viable (568
nm) fluorescent emissions. Data are from two biofilms,
one an untreated control (L−S−), and the other subjected
to PDT (L+S+).
Analysis of CLSM data
Fluorescence intensity profiles (Hope et al., 2002) through
the biofilms were generated by measuring the brightness
of each optical section in the confocal image stack,
for both the viable (488 nm) and non-viable (568
nm) channels, using ImageJ computer software (ImageJ
1.36d, The National Institutes of Health, USA, website:
<http://rsb.info.nih.gov/ij/>). To enable an effective
comparison between the viable and non-viable channels,
these data were normalized against the maximum
image intensity for each individual channel (maximum
value= 1) and plotted against depth into the biofilm. Zero
depth was taken as the top of the confocal image stack.
Projection images were constructed by combining all
confocal optical sections into one image.
Susceptibility of biofilms to chlorhexidine
digluconate
Two pans, each containing five biofilms, were removed
aseptically from the CDFF and placed in a sterile glass
container. To thiswas added 5ml 0.2%CHX(Sigma) or, in
the case of the control pan, 5ml phosphate-buffered saline
(PBS: Oxoid, Basingstoke, UK) and incubated for 1 or
15min. Biofilmswere then prepared for viable counting as
described above. In parallel, PDT was applied to biofilms
of the same age using a regimen of 2.1 J HeNe laser light
with 81.7µMTBO for 1min and then prepared for viable
counting. In addition, the 15min CHX exposure results
were compared with the data generated using the PDT
modalities described above (15min treatment).
Statistical analyses
The statistical significance of the data was ascertained
using the two-tail t-test assuming unequal variance. For
viable counting following PDT, four individual biofilms
were used to determine c.f.u./ml by plating in duplicate,
n= 8. For CHX and TBO studies, three biofilms were
plated in duplicate, n= 6. For ease of interpretation,
viability is recorded as percentage kill as compared with
untreated control.
RESULTS
Effect of PDT on biofilm viability
Table 1 shows the effect of increasing light dose and
photosensitizer concentration on the efficacy of lethal
photosensitization in terms of the percentage of bacteria
killed. The most effective combination of light and
photosensitizer was 94.5 J and 81.7µM TBO, which
produced a significant kill of 97.4%. A reduced TBO
concentration of 65.4µM with the same light dosage
still produced a significant kill of 95.0%. Increasing
photosensitizer concentration to 163.4µM but still using
94.5 J laser light reduced the efficacy of the procedure,
producing a diminished, but significant, kill of 74.4%. A
photosensitizer concentration of 32.7µM in combination
with a light dose of 94.5 J was sufficient to produce a
significant bactericidal effect, with a kill of 82.7%.
Table 1: Effect of laser light intensity and sensitizer concentration on kill
efficacy
Light intensity (J) TBO concentration (µM) % kill
63 32.7 41.9∗
63 0 0∗
0 32.7 72.6∗
63 81.7 69.0
63 0 0∗
0 81.7 36.3∗
94.5 32.7 82.7
94.5 0 0∗
0 32.7 0∗
94.5 65.4 95.0
94.5 0 0∗
0 65.4 0∗
94.5 81.7 97.4
94.5 0 54.4
0 81.7 57.1
94.5 163.4 74.4
94.5 0 0∗
0 163.4 0∗
∗Not significant.
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(b)
Fig. 1: (a) Projection of confocal image stack of a control CDFF-cultivated
multi-species biofilm (L−S−). (b) Projection of confocal image stack of a
CDFF-cultivated multi-species biofilm exposed to 63 J of HeNe laser light
and 81.7µMTBO (L+S+). (a) and (b) Scale bars represent 20µm. Viable
cells, green; non-viable cells, blue.
Reducing the light dosage from 94.5 to 63 J reduced
the bactericidal efficacy of PDT. Laser light (63 J) with
a photosensitizer concentration of 81.7µM produced a
significant kill of 69.0%; however, this kill was less than
that observed at the higher light dosage using the same
photosensitizer concentration, albeit the difference was
not significant. Laser light (63 J) in conjunction with
32.7µM TBO was insufficient to produce a significant
lethal effect.
CLSM studies on biofilms subjected to PDT
Microcolony formations interspersed with water channels
can be seen in the control biofilm shown in Fig 1a. Viable
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Fig. 2: Normalized fluorescence intensity profile of viable and non-viable
stain as a function of depth in a control biofilm (L−S−), as determined by
CLSM.
cells (green) appeared to be far more numerous than the
non-viable cells (blue). (It should be noted that the red,
non-viable stainused in theprocedurewas digitally altered
to appear blue using ImageJ for ease of interpretation.)
Fig. 1b shows a multi-species biofilm that was subjected
to lethal photosensitizationwith 63 J ofHeNe laser light in
the presence of 10µl of 81.7µMTBO.Visually, there was a
discernible difference between this biofilm and the control
(Fig. 1a). The structure of the biofilm seems to have been
disrupted by exposure to the light in the presence of TBO.
In addition, there appeared to be a larger proportion of
non-viable to viable cells as compared with the control
biofilm.
The normalized fluorescence image intensity profile
through the control biofilm (Fig. 2) conformed to those
observed elsewhere (Hope et al., 2002; Hope & Wilson,
2006) in similar supragingival and subgingival plaque
biofilm models. Biofilm that was exposed to 63 J of HeNe
laser light in thepresence ofTBO(Fig. 3) showedabroader
distribution of non-viable fluorescence, particularly in the
upper layers closest to the illumination source.
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Fig. 3: Normalized fluorescence intensity profile of viable and non-viable
stain in biofilms exposed to 63 J of HeNe laser light and 81.7µM TBO
(L+S+), as determined by CLSM.
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Effect of chlorhexidine digluconate on biofilm
viability
Exposure of biofilms to 0.2% CHX for 1min did
not result in a statistically significant reduction in the
number of recovered viable organisms post-exposure
when compared with the control, whereas exposure
for 15min with this treatment resulted in a significant
reduction of 99.7%. Exposure to PDT for 1min using a
combination of 2.1 J of laser light and 81.7µM TBO did
not produce a significant kill, whereas (as described above)
combinations of 63 J (163.8 J/cm2) with 81.7µMTBOand
94.5 J (248 J/cm2) with 32.7, 65.4, 81.7 and 163.4µMTBO
produced significant reductions in biofilm viability.
DISCUSSION
PDT was performed using two light doses, 63 J
(163.8 J/cm2) and 95.4 J (248 J/cm2), with a range of
photosensitizer concentrations, the latter light dosage
proving the most effective.
Inconsistencies in effect of laser and photosensitizer
activity alone on biofilm viability were observed. In all but
one instance, these were not significant. However, 94.5 J
laser light, and 81.7µM TBO alone, produced significant
kills (54.4% and 57.1%, respectively), although these kills
were much lower than those achieved in combination
(97.4%). It is possible that the variability encountered
in these experiments was due to the heterogeneous
nature of these multi-species biofilms, where perhaps
unculturable bacteria accounted for varying proportions
of biofilm biomass. Alternatively, the treatments alone
may have contributed a small antimicrobial effect. Further
experiments, with larger sample sizes are required to build
on this preliminary study.
A combination of 63 J laser light and 81.7µM TBO
produced the greatest bactericidal effect, as determined
by viability studies using plate culture. An increase
in the photosensitizer concentration (to 163µM) did
not effect an increase in bactericidal activity of PDT.
This observation seems counter-intuitive; one would
have envisaged that increasing the concentration of
photosensitizer applied to the biofilm would result in
an increase in kill. However, if the TBO solution was
too concentrated, penetration of the solution by the laser
light would be impeded. Thus a shielding effect (Herzog
et al., 1994) could occur, preventing the excitation of
TBO proximal to the biofilm bacteria, with a consequent
reduction in efficacy of killing. Alternatively, TBO may
also aggregate at higher concentrations, localizing its
presence and preventing adequate pervasion of the target
material. This may also account for the lack of increased
efficacy at higher concentrations (Sternberg & Dolphin,
1996). If the concentration of TBO used is sub-optimal
for the light dose administered, photobleaching will
occur (Rigaut & Vassy, 1991) resulting in degradation of
photosensitizer and diminished bactericidal activity. Thus
there appears likely to be a concentration of TBO optimal
for photosensitization– sufficient toprevent bleachingbut
below a threshold where its presence becomes detrimental
to the procedure.
CLSM studies utilized the BacLightTM bacterial viability
kit (LIVE/DEAD) to determine the viability profile of
bacteria within the biofilms and revealed biofilms of
typical architecture, similar to those observed in other
CLSM studies (e.g. Costerton et al., 1994; Hope et al.,
2002). Microcolonies interspersed with water channels
were visible (Fig. 1a).
Analyses of the control biofilms (L−S−) (Fig. 2)
revealed that in general there was little difference in the
spatial distribution of live cells relative to dead cells, with
the exception that at the margins of the upper and, in
particular, lower biofilm interfaces there seemed to be
a slight increase in dead cells. In the case of the upper
surface it is possible that obligately anaerobic bacteria
were killed during the sampling process (Hope &Wilson,
2006). At the biofilm/substratum interface theremay have
been nutrient limitation or a build up of toxic products
(especially in areas relatively distant from water channels)
that may have resulted in the death of some cells.
Biofilms exposed to laser light and photosensitizer
showed evidence of lethal photosensitization, as indicated
by an increasing proportion of dead cells, particularly in
the upper portion of the biofilm (0–10µm), suggesting
that PDT was most effective in this area (Fig. 3).
In addition to the possible limitations associated with
photosensitizer efficacy discussed above, it is also possible
that, with increasing depth, biofilms became increasingly
more resistant to PDT. This may be due to reduced
growth rate of cells with increasing depth in the biofilm, a
known contributor to antimicrobial resistance in biofilm
populations (Evans et al., 1990; Roberts & Stewart, 2004).
CHX is used in the treatment of a wide range of oral
infections, including periodontitis (Pietruska et al., 2006).
Its efficacy against subgingivallymodelled in vitro biofilms
was compared with that of PDT to provide an indication
of the suitability of PDT as a putative therapeutic regimen
in treating periodontal disease. CHX (at 0.2%) did not
produce a significant kill when applied to the biofilms
for 1min, suggesting that this may be an ineffective
treatment when directed against periodontal plaques of
similar dimensions in situ. CHX did produce a statistically
significant kill after 15min, although this would be an
impractical exposure period clinically. However, it is
possible that a similar kill could have been achieved with
an exposure period somewhere between 1 and 15min
or at increased concentration (not tested). When PDT
was employed with a low light dosage (2.1 J) for 1min,
no significant reduction in viability of the biofilms was
observed. However, as discussed above, comprehensive,
significant kills were achieved with 15min exposure at
increased light intensities, and optimally with a light dose
and photosensitizer concentration of 94.5 J and 81.7µM,
respectively. Hence, from these preliminary in vitro data,
one can conclude that PDT (using TBO and HeNe laser
light) can be as effective as CHX when directed against
biofilms similar to those found in periodontal disease.
The site-specific clinical application of PDT would
enable avoidance of the use of antibiotics (which are
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often used following periodontal surgery) and the
associated problem of perturbation of the indigenous
systemic microflora, for example gastrointestinal upset.
The increasing prevalence of bacterial antibiotic resistance
necessitates the development of alternative antibacterial
therapies. Sublethal concentrations of biocides may also
select for mutants expressing multidrug efflux pumps,
which can also render them antibiotic resistant (Gilbert
et al., 2002a). Thus routine use of antimicrobial oral
health-care products could conceivably select for a
population of bacteria with an intrinsic ability to resist
antibiotic therapy, andconsequently limit the effectiveness
of antibiotic treatment following periodontal surgery.
Development of resistance to chlorhexidine has been
demonstrated in some Gram-negative bacteria including
Pseudomonas aeruginosa (Thomas et al., 2000) and
Klebsiella pneumoniae (Fang et al., 2002). With PDT,
lethal photosensitization mediates bacterial killing via
singlet oxygen and free radicals. Resistance development
would be unlikely owing to the multiplicity of target sites,
which include the outer and plasmamembranes of Gram-
negative bacteria,DNAandphotolabile surface-associated
proteins (Bhatti et al., 1998, 2001), against which the
generated singlet oxygen and free radicals are active.
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